311 related articles for article (PubMed ID: 30103737)
1. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.
Wei DM; Chen WJ; Meng RM; Zhao N; Zhang XY; Liao DY; Chen G
Respir Res; 2018 Aug; 19(1):150. PubMed ID: 30103737
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies.
Wen S; Zhou W; Li CM; Hu J; Hu XM; Chen P; Shao GL; Guo WH
BMC Cancer; 2015 Jul; 15():520. PubMed ID: 26174366
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis.
Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X
Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186
[TBL] [Abstract][Full Text] [Related]
6. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
7. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
Tong M; Wang J; Jiang N; Pan H; Li D
PLoS One; 2017; 12(8):e0182282. PubMed ID: 28797050
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.
Woo T; Okudela K; Yazawa T; Wada N; Ogawa N; Ishiwa N; Tajiri M; Rino Y; Kitamura H; Masuda M
Lung Cancer; 2009 Sep; 65(3):355-62. PubMed ID: 19162366
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
Tian Y; Ma Z; Chen Z; Li M; Wu Z; Hong M; Wang H; Svatek R; Rodriguez R; Wang Z
PLoS One; 2016; 11(7):e0158891. PubMed ID: 27410033
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Ahn C; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
Clin Genitourin Cancer; 2018 Aug; 16(4):e831-e841. PubMed ID: 29551582
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
Luo ZW; Zhu MG; Zhang ZQ; Ye FJ; Huang WH; Luo XZ
BMC Cancer; 2019 Feb; 19(1):123. PubMed ID: 30727976
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
Wang XF; Zhu YT; Wang JJ; Zeng DX; Mu CY; Chen YB; Lei W; Zhu YH; Huang JA
PLoS One; 2017; 12(9):e0185168. PubMed ID: 28934305
[TBL] [Abstract][Full Text] [Related]
14. Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract Urinary Carcinoma? A Retrospective Cohort Study and Meta-Analysis.
Fan B; Zhang H; Jin H; Gai Y; Wang H; Zong H; Jin M; Yang H; Wan S; Zhu J; Xu S; Wang J; Yang D; Song X
Cell Physiol Biochem; 2016; 40(6):1613-1625. PubMed ID: 28006766
[TBL] [Abstract][Full Text] [Related]
15. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Ki-67 in stage I non-small-cell lung cancer: A meta-analysis involving 1931 patients.
Xu J; Liu P; Da J; Hao J; Peng W; Sun G
Pathol Res Pract; 2019 May; 215(5):855-860. PubMed ID: 30871912
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]